Form 13-F position report

* DOLBY LABORATORIES INC

Reported by Clearbridge Investments LLC

Company profile Manager portfolio Source filing
DLB CUSIP 25659T107 Manager CIK 0001348883
Latest reported change

Reported 2,338,304 shares, down 80,490 (3.3%) from the prior quarter.

Reported value -6.0%; share count -3.3% vs. the prior quarter.

Reduced
% of reported 13F value 0.16% This manager · Q1 2024
Shares 2,338,304 Quarter-end amount reported
Reported value $195,879,714 Fair value at quarter end
Consecutive quarters held 44 Through Q1 2024

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Manager history

Quarterly position history

How this manager's reported quarter-end position changed over time.

15 quarters
Quarter Activity Shares Change % of reported 13F Reported value Filed
Q1 2025 Reduced 0 -1,165,919 (-100.0%) 0 $0 2025-05-13
Q4 2024 Reduced 1,165,919 -510,611 (-30.5%) 0.07% $91,058,250 2025-02-12
Q3 2024 Reduced 1,676,530 -325,377 (-16.3%) 0.1% $128,304,844 2024-11-12
Q2 2024 Reduced 2,001,907 -336,397 (-14.4%) 0.13% $158,611,120 2024-08-14
Q1 2024 Reduced 2,338,304 -80,490 (-3.3%) 0.16% $195,879,714 2024-05-13
Q4 2023 Reduced 2,418,794 -111,841 (-4.4%) 0.18% $208,451,638 2024-02-09
Q3 2023 Reduced 2,530,635 -85,031 (-3.3%) 0.19% $200,578,114 2023-11-13
Q2 2023 Reduced 2,615,666 -202,377 (-7.2%) 0.2% $218,878,897 2023-08-11
Q1 2023 Reduced 2,818,043 -85,350 (-2.9%) 0.23% $240,717,240 2023-05-12
Q4 2022 Reduced 2,903,393 -210,060 (-6.7%) 0.2% $204,805,314 2023-02-10
Q3 2022 Reduced 3,113,453 -105,973 (-3.3%) 0.2% $202,841,000 2022-11-14
Q2 2022 Reduced 3,219,426 -99,188 (-3.0%) 0.21% $230,382,000 2022-08-11
Q1 2022 Reduced 3,318,614 -54,073 (-1.6%) 0.2% $259,582,000 2022-05-13
Q4 2021 Reduced 3,372,687 -64,116 (-1.9%) 0.22% $321,147,000 2022-02-11
Q3 2021 Reduced 3,436,803 -37,315 (-1.1%) 0.22% $302,439,000 2021-11-12
Five years are shown. A free account unlocks the complete reported history. Unlock full history
Institutional context

Who else reported the position

465 managers reported * DOLBY LABORATORIES INC for Q1 2024.

Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Added 6,502,463 +107,713 0.01% $544,711,325 44 qtrs
MORGAN STANLEY Added 5,861,955 +972,358 0.04% $491,056,275 44 qtrs
BlackRock Inc Added 5,818,546 +20,861 0.01% $487,419,592 44 qtrs
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC Reduced 4,641,073 -779,947 0.9% $388,782,708 16 qtrs
Clearbridge Investments LLC This report Reduced 2,338,304 -80,490 0.16% $195,879,714 44 qtrs
THE BANK OF NEW YORK MELLON CORPORATION Added 2,324,244 +233,958 0.04% $194,701,915 44 qtrs
Ninety One UK Ltd Reduced 2,284,849 -287,497 0.54% $191,401,801 11 qtrs
STATE STREET CORPORATION Added 1,890,374 +38,490 < 0.01% $158,356,630 44 qtrs
DISCIPLINED GROWTH INVESTORS INC MN Added 1,391,771 +20,450 2.13% $116,588,657 44 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 1,370,095 +150,136 0.01% $115,098,026 44 qtrs
A free account expands this comparison to 25 managers. Create free account
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2024
Filed
May 13, 2024
Filing type
13F-HR
Position type
COM CL A

Voting authority reported

Sole
2,275,694
Shared
0
None
62,610

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.